ProPhase Labs, Inc.
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic…
Insiders
Transactions
| Reported Owner(s) | Position Now | Transaction Date | Type | Position Change | Extra | ||
|---|---|---|---|---|---|---|---|
| RelevantBeneficialStockOwner object (416) |
$150,000
i
Common Stock, par value $0.005
10% Holder
|
04/05/23 |
G
|
50,000 x $0 = $0 |
Footnotes
#1 This transaction involved a gift of securities by the Reporting Person to his son, who shares the Reporting Person's household.
#2 Shares held by Reporting Person's son, who shares the Reporting Person's household.
|
||
| RelevantBeneficialStockOwner object (416) |
$3,433,750
d
Common Stock, par value $0.005
10% Holder
|
04/05/23 |
G
|
50,000 x $0 = $0 |
Footnotes
#1 This transaction involved a gift of securities by the Reporting Person to his son, who shares the Reporting Person's household.
#2 Shares held by Reporting Person's son, who shares the Reporting Person's household.
|
||
| RelevantBeneficialStockOwner object (416) |
$3,483,750
d
Common Stock, par value $0.005
10% Holder
|
04/03/23 |
G
|
100,000 x $0 = $0 |
Footnotes
#1 This transaction involved a gift of securities by the Reporting Person to his son, who does not share the Reporting Person's household.
|
||
| RelevantBeneficialStockOwner object (416) |
$3,583,750
d
Common Stock, par value $0.005
10% Holder
|
02/01/23 |
F
|
268,337 x $8.18 = $2,194,996.66 |
Footnotes
#1 On February 1, 2023, the Reporting Person acquired net 231,663 shares of common stock upon the exercise of stock options to purchase 500,000 shares of common stock, less 268,337 shares of common stock withheld to cover the exercise price and applicable taxes.
|
||
| RelevantBeneficialStockOwner object (416) |
$3,852,087
d
Common Stock, par value $0.005
10% Holder
|
02/01/23 |
M
|
500,000 x $0.60 = $300,000.00 |
Footnotes
#1 On February 1, 2023, the Reporting Person acquired net 231,663 shares of common stock upon the exercise of stock options to purchase 500,000 shares of common stock, less 268,337 shares of common stock withheld to cover the exercise price and applicable taxes.
|
||
Get PRO Today
With PRO you will unlock 31 more insider transactions for ProPhase Labs, Inc.
Individuals
We summarize earnings call passages, compensations, insider transactions and other information for each individual to get the bigger picture:
Individuals
We summarize earnings call passages, compensations, insider transactions and other information for each individual to get the bigger picture: